Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Aug 3, 2015 in Hypertension | 0 comments

In a nutshell

This study aimed to highlight the factors involved in eligibility for renal denervation in patients with resistant hypertension.

Some background

Resistant hypertension is high blood pressure that does not lower when treated with standard medications. Methods for treating resistant hypertension include spironolactone (Aldactone). However, spironolactone does not work in all cases. Renal denervation may be considered in patients who do not respond to spironolactone.

Renal denervation (RDN) is a relatively new procedure that reduces certain nerve impulses to the kidney that are involved in the development of hypertension. There are many serious side effects associated with RDN, such as damage to the arteries of the kidney. The decrease in blood pressure may not be as large as hoped for. Also, the long-term effects of renal denervation are unknown. For these reasons RDN should only be a last resort in certain patients with resistant hypertension.

Methods & findings

The current study aimed to determine which patients with resistant hypertension were or were not appropriate for RDN. 

This study examined 731 resistant hypertension patients referred to specialists for their eligibility for RDN.  At the start of the study the average blood pressure was 176/96 mmHg. Up to 27.2% of patients had not exhausted the treatment options for resistant hypertension.

Approximately 42.5% of patients were eligible for RDN. The main reason for ineligibility was that all other treatments options had not been exhausted. Blood pressure was lowered in 47% of patients after treatment adjustment by blood pressure specialists, including the addition of spironolactone. In some patients, the shape of the renal artery wasn't appropriate for the procedure. 

Patients who were found to be eligible had been treated with a higher number of medications or had higher and more variable blood pressures than those who were not eligible. 

The bottom line

This study concluded that RDN should be considered only after all other treatments have been attempted

What’s next?

If you are struggling with resistant hypertension, discuss with your physician whether or not other medications may be of use.

Published By :

Hypertension

Date :

Mar 24, 2014

Original Title :

Eligibility for Renal Denervation: Experience at 11 European Expert Centers.

click here to get personalized updates